Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Soluble CD206 in metastatic renal cell carcinoma:Relation to clinical–biochemical parameters and patient outcome

Subjects: biomarker; CD206; macrophages

  • Source: Lauridsen, K M, Møller, H J, Kristensen, M W, Fristrup, N, Donskov, F, Hokland, M & Andersen, M N 2025, 'Soluble CD206 in metastatic renal

تفاصيل العنوان

×
Academic Journal

Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies:Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Subjects: Brain neoplasms; Immune checkpoint inhibitors; Neurosurgery

  • Source: Takemura, K, Lemelin, A, Ernst, M S, Wells, J C, Saliby, R M, El Zarif, T, Labaki, C, Basappa, N S, Szabados, B, Powles, T, Davis, I D, Wood, L A, Lalani, A K A, McKay, R R, Lee, J L, Meza, L, Pal, S

تفاصيل العنوان

×
Academic Journal

Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies:Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Subjects: Brain neoplasms; Immune checkpoint inhibitors; Neurosurgery

  • Source: Takemura, K, Lemelin, A, Ernst, M S, Wells, J C, Saliby, R M, El Zarif, T, Labaki, C, Basappa, N S, Szabados, B, Powles, T, Davis, I D, Wood, L A, Lalani, A K A, McKay, R R, Lee, J L, Meza, L, Pal, S

تفاصيل العنوان

×
Academic Journal

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma:extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial

Subjects: advanced renal cell carcinoma; CheckMate 214; dual checkpoint inhibition

  • Source: Tannir, N M, Albigès, L, McDermott, D F, Burotto, M, Choueiri, T K, Hammers, H J, Barthélémy, P, Plimack, E R, Porta, C, George, S, Donskov, F, Atkins, M B, Gurney, H, Kollmannsberger, C K, Grimm,

تفاصيل العنوان

×
Academic Journal

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma:extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial

Subjects: advanced renal cell carcinoma; CheckMate 214; dual checkpoint inhibition

  • Source: Tannir, N M, Albigès, L, McDermott, D F, Burotto, M, Choueiri, T K, Hammers, H J, Barthélémy, P, Plimack, E R, Porta, C, George, S, Donskov, F, Atkins, M B, Gurney, H, Kollmannsberger, C K, Grimm,

تفاصيل العنوان

×
Academic Journal

Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors:the NORDIC-SUN-Trial

Subjects: Biomarkers; Deferred cytoreductive nephrectomy; Immunotherapy

  • Source: Iisager, L, Ahrenfeldt, J, Donskov, F, Ljungberg, B, Bex, A, Lund, L, Lyskjær, I & Fristrup, N 2024, 'Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic

تفاصيل العنوان

×
Academic Journal

Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors:the NORDIC-SUN-Trial

Subjects: Biomarkers; Deferred cytoreductive nephrectomy; Immunotherapy

  • Source: Iisager, L, Ahrenfeldt, J, Donskov, F, Ljungberg, B, Bex, A, Lund, L, Lyskjær, I & Fristrup, N 2024, 'Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic

تفاصيل العنوان

×
  • 1-10 ل  75 نتائج ل ""Renal cell carcinoma""